MECP2 and Global developmental delay: Core symptoms of MECP2 duplication syndrome include developmental delay (100%), severe intellectual disability (99.4%), hypotonia (93.4%), ASD or autistic feature (73.2%), recurrent infections (72.6%), and seizure/epilepsy (59.9%).